Kintara Therapeutics Inc (NASDAQ:KTRA) traded at $0.13 at close of the session on Friday, April 05, made a downward move of -9.46% on its previous day’s price.
Looking at the stock we see that its previous close was $0.14 . In terms of its 52-week price range, KTRA has a high of $5.98 and a low of $0.08. The company’s stock has gained about 36.66% over that past 30 days.
Kintara Therapeutics Inc has a market cap of $7.19 million. Estimates by analysts give the company expected earnings per share (EPS) of $0, with the EPS growth for the year raised at -$0.46 for 2024 and -$0.38 for next year. These figures represent 95.00% and 17.40% growth in EPS for the two years respectively.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the KTRA stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Looking further, we note the current price level is 30.02% off its SMA20 and 21.31% from its 50-day simple moving average. The RSI (14) is pointing at 57.22 while the volatility over the past week is 25.41% and jumps to 13.66% over the past one month. The beta value is 0.51, while the average true range (ATR) is currently pointing at 0.02.
Coming back to Kintara Therapeutics Inc (NASDAQ:KTRA), we note that the average 3-month trading volume was 14.71 million, while that of the preceding 10-day period stands at 31.36 million. Current shares outstanding are 55.30 million.
The insiders hold 0.19% of the company’s shares while institutions hold 0.44%. The data shows that short shares as of Mar 15, 2024, stood at 2.2 million at a short ratio of 0.11. This represents a 5.63% short interest in shares outstanding on Mar 15, 2024. Shares short rose in March from the previous month at 0.41 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -23.29% down in year-to-date price movement.
